Respiratory Disease in Army Recruits. Surveillance Program Overview, 1995-2006

American Journal of Preventive Medicine

Volumn 34, Issue 5, 2008, Pages 389-395

  Lee, Seung eun ^a   Eick, Angelia ^a   Ciminera, Paul ^a  

^a U S ARMY CENTER FOR HEALTH PROMOTION AND PREVENTIVE MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VACCINE; BENZATHINE PENICILLIN; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADOLESCENT; ADULT; ARMY; ARTICLE; CHEMOPROPHYLAXIS; EPIDEMIC; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MILITARY MEDICINE; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; STREPTOCOCCUS GROUP A; SUMMER; VACCINATION; WINTER;

ADOLESCENT; ADULT; DISEASE OUTBREAKS; FEMALE; HUMANS; MALE; MILITARY PERSONNEL; POPULATION SURVEILLANCE; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; STREPTOCOCCUS PYOGENES; UNITED STATES;

EID: 41849151493     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2007.12.027     Document Type: Article

References (40)

1. Lemon H.M., Wise H., and Hamburger M. Bacterial content of air in army barracks. War Med 6 (1944) 92-101
2. Balicer R.D., Huerta M., Levy Y., Davidovitch N., and Grotto I. Influenza outbreak control in confined settings. Emerg Infect Dis 11 (2005) 579-583
3. Fahey T., Stocks N., and Thomas T. Systematic review of the treatment of upper respiratory tract infection. Arch Dis Child 79 (1998) 225-230
4. Bisno A.L., Peter G.S., and Kaplan E.L. Diagnosis of strep throat in adults: Are clinical criteria really good enough?. Clin Infect Dis 35 (2002) 126-129
5. Brundage J.F. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis 6 (2006) 303-312
6. Oxford J.S., Sefton A., Jackson R., Innes W., Daniels R.S., and Johnson N.P. World War I may have allowed the emergence of "Spanish" influenza. Lancet Infect Dis 2 (2002) 111-114
7. Rajagopal S., and Treanor J. Pandemic (avian) influenza. Semin Respir Crit Care Med 28 (2007) 159-170
8. Dudding B.A., Top F.H., Winter P.E., Buescher E.L., Lamson T.H., and Leibovitz A. Acute respiratory disease in military trainees: the adenovirus surveillance program, 1966-1971. Am J Epidemiol 97 (1973) 187-198
9. Buescher E.L. Respiratory disease and the adenoviruses. Med Clin North Am 51 (1967) 769-779
10. Rosenbaum M.J., Edwards E.A., Frank P.F., Pierce W.E., Crawford Y.E., and Miller L.F. Epidemiology and prevention of acute respiratory disease in naval recruits. Am J Public Health Nations Health 55 (1965) 38-46
11. Thomas R.J., Conwill D.E., Morton D.E., Brooks T.J., Holmes C.K., and Mahaffey W.B. Penicillin prophylaxis for streptococcal infections in U.S. navy and marine corps recruit camps, 1951-1985. Rev Infect Dis 10 (1988) 125-130
12. Peters J.E., and Gackstetter G.D. Streptococcus pyogenes transmission among air force recruits: efficacy of surveillance and prophylaxis protocols. Mil Med 163 (1998) 667-671
13. Crum N.F., Russell K.L., Kaplan E.L., et al. Pneumonia outbreak associated with group A streptococcus species at a military training facility. Clin Infect Dis 40 (2005) 511-518
14. Shulman S.T., Stollerman G., Beall B., Dale J.B., and Tanz R.R. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the U.S. Clin Infect Dis 42 (2006) 441-447
15. Denny F.W., Wannamaker L.W., Brink W.R., Rammelkamp C.H., and Custer E.A. Prevention of rheumatic fever; treatment of the preceding streptococcic infection. J Am Med Assoc 143 (1950) 151-153
16. Chamovitz R., Catanzaro F.J., Stetson C.A., and Rammelkamp C.H. Prevention of rheumatic fever by treatment of previous streptococcal infections. I. Evaluation of benzathine penicillin G. N Engl J Med 251 (1954) 466-471
17. Hilleman M.R., Stallones R.A., Gauld R.L., Warfield M.S., and Anderson S.A. Vaccination against acute respiratory illness of adenovirus (RI-APC-ARD) etiology. Am J Public Health Nations Health 47 (1957) 841-847
18. Brundage J.F., Gunzenhauser J.D., Longfield J.N., et al. Epidemiology and control of acute respiratory diseases with emphasis on group A beta-hemolytic streptococcus: a decade of U.S. army experience. Pediatrics 97 6 Pt 2 (1996) 964-970
19. Office of the Army Surgeon General. Acute respiratory disease surveillance programMemorandumDASG-PPM-NC (2006). http://amsa.army.mil/documents/Army_PDFs/Army%20Acute%20Respiratory%20Di sease%20Surveillance%20Program.pdf amsa.army.mil/documents/Army_PDFs/Army%20Acute%20Respiratory%20Disease%2 0Surveillance%20Program.pdf.
20. Johnson S., Streamer C.W., and Williams P.M. An evaluation of a streptococcal control program. Am J Public Health Nations Health 54 (1964) 487-500
21. Department of the Army. Preventive medicine. Report No.: Army Regulation 40-5, 2005.
22. CDC. Nationally notifiable infectious diseases, U.S. (2007). http://www.cdc.gov/epo/dphsi/phs/infdis2007.htm www.cdc.gov/epo/dphsi/phs/infdis2007.htm.
23. Army Medical Surveillance Activity. Tri-service reportable events: guidelines and case definitions (2004). http://amsa.army.mil/Documents/DoD_PDFs/May04TriServREGuide.pdf amsa.army.mil/Documents/DoD_PDFs/May04TriServREGuide.pdf.
24. Rubertone M.V., and Brundage J.F. The defense medical surveillance system and the department of defense serum repository: glimpses of the future of public health surveillance. Am J Public Health 92 (2002) 1900-1904
25. Veasy L.G., Tani L.Y., Daly J.A., et al. Temporal association of the appearance of mucoid strains of streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 113 3 Pt 1 (2004) e168-e172
26. Russell K.L., Hawksworth A.W., Ryan M.A., et al. Vaccine-preventable adenoviral respiratory illness in U.S. military recruits, 1999-2004. Vaccine 24 (2006) 2835-2842
27. Gray G.C., Goswami P.R., Malasig M.D., et al. Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. Clin Infect Dis 31 (2000) 663-670
28. National Center for Infectious Diseases, Respiratory and Enteric Viruses Branch. Adenoviruses. www.cdc.gov/ncidod/dvrd/revb/respiratory/eadfeat.htm.
29. Currie B.J., Burt T., and Kaplan E.L. Penicillin concentrations after increased doses of benzathine penicillin G for prevention of secondary rheumatic fever. Antimicrob Agents Chemother 38 (1994) 1203-1204
30. Gray G.C., Escamilla J., Hyams K.C., Struewing J.P., Kaplan E.L., and Tupponce A.K. Hyperendemic streptococcus pyogenes infection despite prophylaxis with penicillin G benzathine. N Engl J Med 325 (1991) 92-97
31. Wang J.H., Liu Y.C., Cheng D.L., et al. Role of benzathine penicillin G in prophylaxis for recurrent streptococcal cellulitis of the lower legs. Clin Infect Dis 25 (1997) 685-689
32. Lejbkowicz F., Samet L., Belavsky L., and Bitterman-Deutsch O. Impetigo in soldiers after hand-to-hand combat training. Mil Med 170 (2005) 972-974
33. Gunzenhauser J.D., Longfield J.N., Brundage J.F., Kaplan E.L., Miller R.N., and Brandt C.A. Epidemic streptococcal disease among army trainees, July 1989 through June 1991. J Infect Dis 172 (1995) 124-131
34. Gray G.C., Callahan J.D., Hawksworth A.W., Fisher C.A., and Gaydos J.C. Respiratory diseases among U.S. military personnel: countering emerging threats. Emerg Infect Dis 5 (1999) 379-385
35. Huovinen P., Lahtonen R., Ziegler T., et al. Pharyngitis in adults: the presence and coexistence of viruses and bacterial organisms. Ann Intern Med 110 (1989) 612-616
36. Factor S.H., Levine O.S., Schwartz B., et al. Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis 9 (2003) 970-977
37. Cornaglia G., Ligozzi M., Mazzariol A., Valentini M., Orefici G., and Fontana R. Rapid increase of resistance to erythromycin and clindamycin in streptococcus pyogenes in Italy, 1993-1995. Emerg Infect Dis 2 (1996) 339-342
38. McNeil S.A., Halperin S.A., Langley J.M., et al. Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 41 (2005) 1114-1122
39. ClinicalTrials.gov. A clinical trial to evaluate the safety, efficacy, and immunogenicity of DR-5001. clinicaltrials.gov/ct/show/NCT00382408?order=1.
40. Sobal J., and Loveland F.C. Infectious disease in a total institution: a study of the influenza epidemic of 1978 on a college campus. Public Health Rep 97 (1982) 66-72